StockHealthcare · Biotechnology

$CRVO

CervoMed Inc.

Price · $CRVOvia TradingView

AI sentiment · 7d0 articles

No enriched coverage for $CRVO in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $CRVO in the last 30 days.

Number of shareholders of CervoMed Inc. – NASDAQ:CRVO

This article provides details regarding the number of shareholders for CervoMed Inc., traded under the NASDAQ:CRVO symbol. The information is presented on a TradingView page, which also lists various financial and market data resources available for the company. The content primarily focuses on the display of shareholder data, emphasizing that the market is closed without any trades.

NOV 24·GlobeNewswire

CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease ( CTAD ) Conference

Late-breaking oral presentation by a leading global authority in Dementia with Lewy bodies ( DLB ) to highlight updated data from Phase 2b study on neflamapimod treatment for ...

NOV 5·Benzinga

This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday - CervoMed ( NASDAQ:CRVO ) , Ascentage Pharma Group ( NASDAQ:AAPG )

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

via TradingView

News on $CRVO

All news →